Læknaneminn - 01.04.1997, Blaðsíða 131

The drug-AlDS hypothesis *
of thousands of scientific reputations that are exclu-
sively built on HIV 7'n,
3) The numerous medical and social benefits avail-
able to HlV-positive activists and patients J52,
4) The staggering commercial interests in HlV-tests,
over 20 million tests per year at $ 50 or more in the US
alone, HlV-vaccines and anti-HIV drugs,
5) The prospects of numerous complaints and mal-
pratice suits against the HIV/AIDS orthodoxy from
those who were told they are destined to die based on
HIV tests or were helped to die with AZT,
6) The prospect of a profound ioss of confidence of
the American public in its medical and scientific elite
7, 11
Thus the current HIV/AIDS orthodoxy cannot
afford the drug hypothesis, and must do everything in
its power to keep it from being presented to the
American people.
Likewise, the $15 billion federal establishment that
conducts the War on Drugs would risk its large budget
and thousands of career positions if the War on Drugs
were won in the name of the hypothesis that drugs
cause AIDS.
In sum, the drug hypothesis is testable and predicts
that AIDS is entirely preventable and treatable by con-
troling drug use. The solution of AIDS and significant
progress in the War on Drugs are as close as a very
testable and affordable non-HIV/AIDS hypothesis.
ACKNOWLEDGEMENTS.
We thank Fred Cline, Harry Haverkos, Phil
Johnson, Serge Lang, Russell Schoch and Richard
Strohman for information and advice, and Siggi
Duesberg for review and preparation of the manu-
script. This investigation was supported in part by the
Council for Tobacco Research, USA, and private dona-
tions from Robert Leppo, San Francisco, Tom Boulger,
Los Angeles, Carol J. Wilhelmy, San Mateo, the partic-
ipants of the Anthony Robbins Life Mastery University
1995 and 1996, Robbins Research International, San
Diego, and a foundation that prefers to remain anony-
mous.
REFERENCES
1. Moberg CL, Cohn ZA. Rene Jules Dubos. Sci Am 1991; 264: 66-
74.
2. Feynman R. Surely you must be joking, Mr. Feynman. Bantam, New
York, 1985.
3. Centers for Disease Control and Prevention. U.S. HIV and AIDS
cases reported through December 1995. HIV/AIDS Surveillance
Report 1995; 7: 1-39.
4. Institute of Medicine, National Academy of Sciences. Confronting
AIDS. National Academy Press, Washington, DC, 1986.
5. Institute of Medicine. Confronting AIDS—Update 1988. National
Academy Press, Washington, DC, 1988.
6. AdamsJ. AIDS: TheHIVMyth. St. Martin’s Press, New York, 1989.
7. Hodgkinson N. AIDS: the failure of contemporary science. Fourth
Estate, London, UK, 1996.
8. Rothman S. Remarks on sex, age and racial distribution of Kaposi’s
sarcoma and on possible pathogenic factors. Acta Unio Int Contra
Cancrum 1962; 18: 326.
9. Oettle AG. Geographical and racial differences in the frequencies of
Kaposi’s sarcoma as evidence of environmental or genetic causes. Acta
Unio Int Contra Cancrum 1962; 18: 330-362.
10. Springer Verlag. 50 Jahre Springer - 50 Jahre Zeitzeuge. Axel
Springer Verlag, Hamburg, 1996.
11. Duesberg P. Inventing the AIDS Virus. Regnery Publishing Inc.,
Washington, 1996.
12. Horton R. Truth and heresy about AIDS. The New York Review
1996; 43: 14, 16-20, May 23.
13. Institute of Medicine. Confronting AIDS. National Academy Press,
Washington, DC, 1986.
14. Anonymous (eds.) The relationship between Human
Immunodeficiency Virus and the Acquired Immunodeficiency
Syndrome (1996), National Institute for Allergy & Infectious
Diseases, Bethesda, MD, .
15. Altman LK. Researchers believe AIDS virus is found. New York
Times (New York) 1984: Cl, C3, April 24.
16. Cohen J. The Duesberg Phenomenon. Science 1994; 266: 1642-
1649.
17. Centers for Disease Control and Prevention. 1993 revised classifica-
tion system for HIV infection and expanded surveillance case defini-
tion for AIDS among adolescents and adults. Morb Mort Weekly Rep
1992; 4l(No. RR17): 1-19.
18. Duesberg PH. Infectious AIDS - stretching the germ theory beyond
its limits. Int Arch Allergy Immunol 1994; 103: 131-142.
19. Auerbach DM, Darrow WW, Jaffe HW, Curran JW. Cluster of cases
of the Acquired Immune Deficiency Syndrome patients linked by sex-
ual contact. Am J Med 1984; 76: 487-492.
20. Bregman DJ, Langmuir AD. Farr’s law applied to AIDS projections.
J Am Med Assoc 1990; 263: 50-57.
21. N ational Commission on AIDS. The Twin Epidemics of Substance
Use and HIV. July 1991;
22. Duesberg P. Duesberg’s questions. C&EN 1996; 4, 40.
23. Duesberg P. Is HIV the cause of AIDS? (letter). Lancet 1995; 346:
1371-1372.
24. Duesberg P. Foreign-protein-mediated immunodeficiency in hemo-
philiacs with and without HIV. Genetica 1995; 95: 51-70.
25. Duesberg P. How much longer can we afford the AIDS virus monop-
oly?, in AIDS: virus or drug-induced?, P. Duesberg (eds.) Kluwer,
Dordrecht, Netherlands, 1996; 241-270.
26. Duesberg PH. AIDS acquired by drug consumption and other non-
contagious risk factors. Pharmacology & Therapeutics 1992; 55:
201-277.
27. Drotman DP, Peterman TA, Friedman-Kien AE. Kaposi’s sarcoma.
How can epidemiology help find the cause? Dermatoepidemiology
1995; 13: 575-582.
28. Bennett A, Sharpe A. AIDS fight is skewed by federal campaign exag-
gerating risks. Wall Street Journal 1996: 1, A6, May 1.
29. Krieger L. 1 in 300 U.S. adults infected, says report. SF Examiner
(San Francisco) 1996: A8, July 7.
30. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Leigh-
Brown AJ. Human immunodeficiency virus-infected individuals con-
tain provirus in small numbers of peripheral mononuclear cells and at
low copy numbers. J Virol 1990; 64: 864-872.
31. Duesberg PH, Bialy H. Duesberg and the right of reply according to
Maddox-Nature, in AIDS: virus- or drug induced?, P. H. Duesberg
(eds.) Kluwer Academic Publishers, Dordrecht/Boston/London,
LÆKNANEMINN
129 1- tbl. 1997, 50. árg.